- Current report filing (8-K)
August 19 2010 - 4:18PM
Edgar (US Regulatory)
UNITED
STATES SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): August 19,
2010
TIENS
BIOTECH GROUP (USA), INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-32477
|
|
75-2926439
|
(State
or other jurisdiction of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer
Identification
Number)
|
No
. 6,
Yuanquan Road, Wuqing
New-Tech Industrial Park, Tianjin,
China
301700
(Address
of principal executive offices)
Registrant's
telephone number, including area code:
(86)
22
-
8213-7658
Not
applicable
(Former
name or former address, if changed since last report.)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2.):
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
materials pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item 2.02
Results of Operations and
Financial Condition.
On August
19, 2010, Tiens Biotech Group (USA), Inc. (the “Company”) issued a press release
reporting the Company’s financial results for the fiscal quarter ended June 30,
2010. The full text of the press release is set forth in Exhibit 99.1
attached hereto.
Item
9.01
Financial
Statements and Exhibits.
|
Exhibit
Number
|
Description
|
|
99.1
|
Press
release, dated August 19,
2010.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
TIENS
BIOTECH GROUP (USA), INC.
|
|
|
|
|
|
|
|
|
Date: August
19, 2010
|
By:
|
/s/ Jinyuan
Li
|
|
|
|
Name:
Jinyuan Li
|
|
|
|
Title:
Chief Executive Officer
|
|
|
|
|
|
Exhibits
Exhibit
Number
|
|
Description
|
|
|
|
99.1
|
|
Press
release, dated August 19, 2010.
|
Tiens Biotech GR Usa (AMEX:TBV)
Historical Stock Chart
From May 2024 to Jun 2024
Tiens Biotech GR Usa (AMEX:TBV)
Historical Stock Chart
From Jun 2023 to Jun 2024